0001213900-24-089635.txt : 20241022 0001213900-24-089635.hdr.sgml : 20241022 20241022160058 ACCESSION NUMBER: 0001213900-24-089635 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241022 FILED AS OF DATE: 20241022 DATE AS OF CHANGE: 20241022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SciSparc Ltd. CENTRAL INDEX KEY: 0001611746 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-AUTO DEALERS & GASOLINE STATIONS [5500] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38041 FILM NUMBER: 241386321 BUSINESS ADDRESS: STREET 1: 20 RAUL WALLENBERG STREET, TOWER A CITY: TEL AVIV STATE: L3 ZIP: 6971916 BUSINESS PHONE: 972-3-6103100 MAIL ADDRESS: STREET 1: 20 RAUL WALLENBERG STREET, TOWER A CITY: TEL AVIV STATE: L3 ZIP: 6971916 FORMER COMPANY: FORMER CONFORMED NAME: SciSparc Ltd./ADR DATE OF NAME CHANGE: 20210129 FORMER COMPANY: FORMER CONFORMED NAME: Therapix Biosciences Ltd. DATE OF NAME CHANGE: 20140624 6-K 1 ea0218246-6k_scisparc.htm REPORT OF FOREIGN PRIVATE ISSUER
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of October 2024 (Report No. 1)

 

Commission file number: 001-38041

 

SCISPARC LTD.

(Translation of registrant’s name into English)

 

20 Raul Wallenberg Street, Tower A,

Tel Aviv 6971916 Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F       Form 40-F 

 

 

 

 

 

 

CONTENTS

 

On October 22, 2024, SciSparc Ltd. (the “Company”) convened its Annual General Meeting of Shareholders (the “Annual Meeting”); however, it was adjourned for one day to the same time and place due to lack of quorum. Accordingly, the Company’s adjourned Annual Meeting will be convened on Wednesday, October 23, 2024, at 8:00 a.m. (Eastern Time) / 3:00 p.m. (Israel time) and will be held at the Company’s offices, 20 Raul Wallenberg Street, Tower A Tel Aviv 6971916 Israel (the “Adjourned Annual Meeting”). If a quorum is not present within half an hour, any number of shareholders who are present in person or proxy, or who have delivered a proxy card, will constitute a quorum, and shall be entitled to deliberate and to resolve in respect of the matter for which the Annual Meeting was convened. Proxy cards delivered for the Annual Meeting will be voted at the Adjourned Annual Meeting.

 

This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company’s registration statements on Form F-3 (File Nos. 333-275305333-269839333-266047333-233417333-248670 and 333-255408) and on Form S-8 (File Nos. 333-278437 and 333-225773) filed with the Securities and Exchange Commission to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SciSparc Ltd.
   
Date: October 22, 2024 By: /s/ Oz Adler
    Name: Oz Adler
    Title: Chief Executive Officer

 

 

 

2